OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • July 19th, 2019 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 19th, 2019 Company Industry JurisdictionCASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $.01 per share (the “Common Shares”), on the terms set forth in this agreement (this “Agreement”).
AMENDMENT NO. 1 TO COMMON STOCK SALES AGREEMENTCommon Stock Sales Agreement • July 19th, 2019 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 19th, 2019 Company Industry JurisdictionCASI Pharmaceuticals, Inc.(the “Company”) and H.C. Wainwright & Co., LLC (“HCW”) are parties to that certain Common Stock Sales Agreement dated February 23, 2018 (the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement.